Published on 8 Feb 2024 on GuruFocus.com via Yahoo Finance
Prestige Consumer Healthcare Inc. (PBH) Reports Modest Revenue and EPS Growth in Q3 Fiscal 2024
Revenue: Q3 revenue increased by 2.6% year-over-year to $282.7 million.Net Income: Q3 net income rose to $53.0 million, a 2.2% increase from the previous year.Earnings Per Share (EPS): Diluted EPS for Q3 was $1.06, up from $1.04 year-over-year.Free Cash Flow: Non-GAAP free cash flow for Q3 reached $69.5 million, compared to $53.1 million in the prior year.Leverage Ratio: Reduced to 2.9x at the end of Q3.Full-Year Outlook: Fiscal 2024 earnings outlook raised to approximately $4.33 per diluted share.
Warning! GuruFocus has detected 11 Warning Signs with ARES.
Prestige Consumer Healthcare Inc (NYSE:PBH) released its 8-K filing on February 8, 2024, detailing its financial performance for the third quarter of fiscal year 2024, which ended on December 31, 2023. The company, a leading provider of over-the-counter healthcare products, reported a revenue increase of 2.6% to $282.7 million, compared to the same quarter in the previous year. The growth was attributed to strong performance in the Eye & Ear Care category in North America and the Hydralyte brand in the International segment.